Dieci MV - Search Results

1

A multivariable prognostic score to guide systemic therapy in early-stage HER2-positive breast cancer: a retrospective study with an external evaluation.

Prat A, Guarneri V, Paré L, Griguolo G, Pascual T, Dieci MV, Chic N, González-Farré B, Frassoldati A, Sanfeliu E, Cejalvo JM, Muñoz M, Bisagni G, Brasó-Maristany F, Urso L, Vidal M, Brandes AA, Adamo B, Musolino A, Miglietta F, Conte B, Oliveira M, Saura C, Pernas S, Alarcón J, Llombart-Cussac A, Cortés J, Manso L, López R, Ciruelos E, Schettini F, Villagrasa P, Carey LA, Perou CM, Piacentini F, D'Amico R, Tagliafico E, Parker JS, Conte P. Prat A, et al. Among authors: dieci mv. Lancet Oncol. 2020 Nov;21(11):1455-1464. doi: 10.1016/S1470-2045(20)30450-2. Lancet Oncol. 2020. PMID: 33152285 Free PMC article. Clinical Trial.

2

Comparison of HER-2 and hormone receptor expression in primary breast cancers and asynchronous paired metastases: impact on patient management.

Guarneri V, Giovannelli S, Ficarra G, Bettelli S, Maiorana A, Piacentini F, Barbieri E, Dieci MV, D'Amico R, Jovic G, Conte P. Guarneri V, et al. Among authors: dieci mv. Oncologist. 2008 Aug;13(8):838-44. doi: 10.1634/theoncologist.2008-0048. Epub 2008 Jul 23. Oncologist. 2008. PMID: 18650259 Free article.

3

Anti-HER2 neoadjuvant and adjuvant therapies in HER2 positive breast cancer.

Guarneri V, Barbieri E, Dieci MV, Piacentini F, Conte P. Guarneri V, et al. Among authors: dieci mv. Cancer Treat Rev. 2010 Nov;36 Suppl 3:S62-6. doi: 10.1016/S0305-7372(10)70022-0. Cancer Treat Rev. 2010. PMID: 21129613 Review.

4

Timing for starting second-line therapy in recurrent ovarian cancer.

Guarneri V, Barbieri E, Dieci MV, Piacentini F, Conte P. Guarneri V, et al. Among authors: dieci mv. Expert Rev Anticancer Ther. 2011 Jan;11(1):49-55. doi: 10.1586/era.10.204. Expert Rev Anticancer Ther. 2011. PMID: 21166510 Review.

5

Magnetic resonance imaging and ultrasonography in predicting infiltrating residual disease after preoperative chemotherapy in stage II-III breast cancer.

Guarneri V, Pecchi A, Piacentini F, Barbieri E, Dieci MV, Ficarra G, Tazzioli G, Frassoldati A, Battista R, Canossi B, Mauri C, D'Amico R, Conte P, Torricelli P. Guarneri V, et al. Among authors: dieci mv. Ann Surg Oncol. 2011 Aug;18(8):2150-7. doi: 10.1245/s10434-011-1590-x. Epub 2011 Feb 8. Ann Surg Oncol. 2011. PMID: 21301969

6

Posterior reversible encephalopathy syndrome during ipilimumab therapy for malignant melanoma.

Maur M, Tomasello C, Frassoldati A, Dieci MV, Barbieri E, Conte P. Maur M, et al. Among authors: dieci mv. J Clin Oncol. 2012 Feb 20;30(6):e76-8. doi: 10.1200/JCO.2011.38.7886. Epub 2011 Dec 27. J Clin Oncol. 2012. PMID: 22203769 No abstract available.

7

Enhancing intracellular taxane delivery: current role and perspectives of nanoparticle albumin-bound paclitaxel in the treatment of advanced breast cancer.

Guarneri V, Dieci MV, Conte P. Guarneri V, et al. Among authors: dieci mv. Expert Opin Pharmacother. 2012 Feb;13(3):395-406. doi: 10.1517/14656566.2012.651127. Epub 2012 Jan 21. Expert Opin Pharmacother. 2012. PMID: 22263900 Review.

8

Predictors of human epidermal growth factor receptor 2 fluorescence in-situ hybridisation amplification in immunohistochemistry score 2+ infiltrating breast cancer: a single institution analysis.

Dieci MV, Barbieri E, Bettelli S, Piacentini F, Omarini C, Ficarra G, Balduzzi S, Dominici M, Conte P, Guarneri V. Dieci MV, et al. J Clin Pathol. 2012 Jun;65(6):503-6. doi: 10.1136/jclinpath-2011-200643. Epub 2012 Mar 3. J Clin Pathol. 2012. PMID: 22389512

9

Discordance in receptor status between primary and recurrent breast cancer has a prognostic impact: a single-institution analysis.

Dieci MV, Barbieri E, Piacentini F, Ficarra G, Bettelli S, Dominici M, Conte PF, Guarneri V. Dieci MV, et al. Ann Oncol. 2013 Jan;24(1):101-8. doi: 10.1093/annonc/mds248. Epub 2012 Sep 20. Ann Oncol. 2013. PMID: 23002281 Free article.

10

Relapsed triple-negative breast cancer: challenges and treatment strategies.

Guarneri V, Dieci MV, Conte P. Guarneri V, et al. Among authors: dieci mv. Drugs. 2013 Aug;73(12):1257-65. doi: 10.1007/s40265-013-0091-6. Drugs. 2013. PMID: 23842749 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

177 results

Search Page

Filters